NanJing Pharmaceutical Company Limited

600713

CNE000000KV1

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
4.86 ^CNY	+1.89%		+3.40%	+0.41%

Apr. 29	NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 08	NanJing Medical Plans to Issue Up to 6 Billion Yuan in Ultra Short-Term Bonds	MT

NanJing Pharmaceutical Company Limited(XSSC:600713) added to S&P Global BMI Index

September 18, 2023 at 12:00 am EDT

Latest news about NanJing Pharmaceutical Company Limited

NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
NanJing Medical Plans to Issue Up to 6 Billion Yuan in Ultra Short-Term Bonds	Apr. 08	MT
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 06	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
NanJing Pharmaceutical Company Limited(XSSC:600713) added to S&P Global BMI Index	23-09-18	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
NanJing Pharmaceutical Company Limited entered into Framework Agreement to acquire 55% stake in Suzhou Tianqing Xingwei Pharmaceutical Co., Ltd., a 55% stake in Zhejiang Tianqing Zhongwei Pharmaceutical Co., Ltd., and a 100% of Lianyungang Chia Tai-Tianqing Pharmaceutical Co., Ltd.	22-12-20	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-23	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
NanJing Medical’s Controlling Shareholder Boosts Stake to 44.2% For $158 Million	22-02-21	MT
NanJing Pharmaceutical Company Limited announced that it has received CNY 997.999997 million in funding from Nanjing XinGong Investment Group Co., Ltd	22-02-13	CI
Sichuan Luyan Pharmaceutical Co., Ltd. agreed to acquire Sichuan Yatong Pharmaceutical Co., Ltd. from NanJing Pharmaceutical Company Limited for CNY 19.9 million.	21-11-08	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
NanJing Pharmaceutical Company Limited announced that it expects to receive CNY 999.999998 million in funding from Nanjing XinGong Investment Group Co., Ltd	21-09-09	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-20	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-26	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-21	CI
NanJing Pharmaceutical Company Limited Declares Distribution for 2019, Payable on June 24, 2020	20-06-15	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-29	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-30	CI

Chart NanJing Pharmaceutical Company Limited

Duration

Period

Chart NanJing Pharmaceutical Company Limited

More charts

NanJing Pharmaceutical Company Limited is a China-based company principally engaged in the pharmaceutical distribution business. The Company's principal businesses include the pharmaceutical wholesale, pharmaceutical retail, pharmaceutical-Internet + business, as well as the pharmaceutical third-party logistics services. The Company mainly conducts its business in domestic market.

Sector

Pharmaceuticals

Calendar

2024-05-30 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
NANJING PHARMACEUTICAL COMPANY LIMITED	+0.41%	880M
MCKESSON CORPORATION	+14.53%	69.79B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+7.11%	8.2B
HUADONG MEDICINE CO., LTD	-20.55%	7.96B
SINOPHARM GROUP CO. LTD.	-3.96%	7.91B
H. LUNDBECK A/S	+2.32%	4.69B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.32B
EBOS GROUP LIMITED	-1.24%	3.99B
GALENICA AG	-3.78%	3.81B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+21.42%	3.62B